<DOC>
	<DOCNO>NCT02235766</DOCNO>
	<brief_summary>Purpose observational study ass capability satellite tele-echocardiography ( STE ) system acquire transmit echocardiographic image clip echocardiographic core laboratory ( ECL ) real time mode without loss quality . Additionally prognostic efficacy specific echo parameter cardiac resynchronization therapy response evaluate .</brief_summary>
	<brief_title>Corelab Remotely Echocardiographic Imaging Acquisition Cardiac Resynchronization Therapy Candidates</brief_title>
	<detailed_description>CORELAB-CRT prospective multi center Italian observational study . All echo image clip transmit use integrate satellite transmission system . All echo assessment perform accordance center clinical practice also use investigate prognostic efficacy echo parameter term response cardiac resynchronization therapy ( CRT ) . All commercially available multi-chamber CRT-D device manufacturer allow observational study . Any compatible market release right atrial , right ventricular leave ventricular lead manufacturer allow . The echocardiography device model use perform echo image patient participate analysis GE Vivid 7 , GE Vivid 9 GE Vivid I , accord model use clinical practice hospital .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . NYHA class II , III ambulatory IV : QRS complex duration ≥120msec ; Ejection fraction ≤35 % . 2 . Optimized medical treatment ; 3 . Patient sinus rhythm ; 4 . Patient willing able sign inform consent form . 1 . Unstable angina , acute myocardial infarction , coronaryaortic bypass graft percutaneous transluminal coronary angioplasty within past 3 month ; 2 . Cerebral vascular attack transient ischemic attack within last month ; 3 . Chronic atrial arrhythmia , paroxysmal atrial fibrillation event ; 4 . Patients already implant ICD CRT device ; 5 . Pacemaker dependency ventricular pace percentage ≥10 % ; 6 . Valvular disease indication surgical correction ≤12 month survival expectancy ; 7 . Mechanical right ventricular valve ; 8 . Patient enrol intend participate another clinical trial may impact study endpoint ; 9 . Pregnancy breastfeeding ; 10 . Previous heart transplant ; 11 . Refusal study inform consent ; 12 . Expected lack compliance followup ; 13 . Patient le 18 year age ; 14 . Patient 's life expectancy le 6 month opinion physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Satellite Tele-Echocardiography</keyword>
</DOC>